{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:24:27Z","timestamp":1793039067907,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,18]]},"DOI":"10.7759\/cureus.71768","type":"journal-article","created":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T08:47:48Z","timestamp":1729241268000},"source":"Crossref","is-referenced-by-count":6,"title":["Incidence of Gastric Adenocarcinoma in Those With Gastric Atrophy: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Eoghan","family":"Burke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Harkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayilone","family":"Arumugasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-017-0708-4","article-title":"Adenocarcinoma risk in gastric atrophy and intestinal metaplasia: a systematic review","volume":"17","author":"Spence AD","year":"2017","unstructured":"Spence AD, Cardwell CR, McMenamin \u00daC, Hicks BM, Johnston BT, Murray LJ, Coleman HG. Adenocarcinoma risk in gastric atrophy and intestinal metaplasia: a systematic review. BMC Gastroenterol. 2017, 17:157. 10.1186\/s12876-017-0708-4","journal-title":"BMC Gastroenterol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.gtc.2013.01.002","article-title":"Gastric cancer: overview","volume":"42","author":"Correa P","year":"2013","unstructured":"Correa P. Gastric cancer: overview. Gastroenterol Clin North Am. 2013, 42:211-7. 10.1016\/j.gtc.2013.01.002","journal-title":"Gastroenterol Clin North Am"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/jso.23262","article-title":"Gastric cancer epidemiology and risk factors","volume":"107","author":"Guggenheim DE","year":"2013","unstructured":"Guggenheim DE, Shah MA. Gastric cancer epidemiology and risk factors. J Surg Oncol. 2013, 107:230-6. 10.1002\/jso.23262","journal-title":"J Surg Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.5230\/jgc.2011.11.3.135","article-title":"Gastric cancer epidemiology in Korea","volume":"11","author":"Shin A","year":"2011","unstructured":"Shin A, Kim J, Park S. Gastric cancer epidemiology in Korea. J Gastric Cancer. 2011, 11:135-40. 10.5230\/jgc.2011.11.3.135","journal-title":"J Gastric Cancer"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol29010005","article-title":"HMGA1 has predictive value in response to chemotherapy in gastric cancer","volume":"29","author":"P\u00e1dua D","year":"2021","unstructured":"P\u00e1dua D, Pinto DF, Figueira P, Pereira CF, Almeida R, Mesquita P. HMGA1 has predictive value in response to chemotherapy in gastric cancer. Curr Oncol. 2021, 29:56-67. 10.3390\/curroncol29010005","journal-title":"Curr Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s10120-018-0812-3","article-title":"The significance of OLGA and OLGIM staging systems in the risk assessment of gastric cancer: a systematic review and meta-analysis","volume":"21","author":"Yue H","year":"2018","unstructured":"Yue H, Shan L, Bin L. The significance of OLGA and OLGIM staging systems in the risk assessment of gastric cancer: a systematic review and meta-analysis. Gastric Cancer. 2018, 21:579-87. 10.1007\/s10120-018-0812-3","journal-title":"Gastric Cancer"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"Moher D","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009, 151:264-9, W64. 10.7326\/0003-4819-151-4-200908180-00135","journal-title":"Ann Intern Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.15693","article-title":"Consistency between the endoscopic Kyoto classification and pathological updated Sydney system for gastritis: a cross-sectional study","volume":"37","author":"Toyoshima O","year":"2022","unstructured":"Toyoshima O, Nishizawa T, Yoshida S, et al.. Consistency between the endoscopic Kyoto classification and pathological updated Sydney system for gastritis: a cross-sectional study. J Gastroenterol Hepatol. 2022, 37:291-300. 10.1111\/jgh.15693","journal-title":"J Gastroenterol Hepatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan-a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani M","year":"2016","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-a web and mobile app for systematic reviews. Syst Rev. 2016, 5:210. 10.1186\/s13643-016-0384-4","journal-title":"Syst Rev"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jncc.2024.05.001","article-title":"Comparative study of cancer profiles between 2020 and 2022 using global cancer statistics (GLOBOCAN)","volume":"4","author":"Cao W","year":"2024","unstructured":"Cao W, Qin K, Li F, Chen W. Comparative study of cancer profiles between 2020 and 2022 using global cancer statistics (GLOBOCAN). J Natl Cancer Cent. 2024, 4:128-34. 10.1016\/j.jncc.2024.05.001","journal-title":"J Natl Cancer Cent"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-019-01639-w","article-title":"Risk of gastric cancer in the second decade of follow-up after Helicobacter pylori eradication","volume":"55","author":"Take S","year":"2020","unstructured":"Take S, Mizuno M, Ishiki K, et al.. Risk of gastric cancer in the second decade of follow-up after Helicobacter pylori eradication. J Gastroenterol. 2020, 55:281-8. 10.1007\/s00535-019-01639-w","journal-title":"J Gastroenterol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1080\/00365521.2018.1477987","article-title":"Occurrence of gastric cancer in patients with atrophic gastritis during long-term follow-up","volume":"53","author":"Zhang L","year":"2018","unstructured":"Zhang L, Liu Y, You P, Feng G. Occurrence of gastric cancer in patients with atrophic gastritis during long-term follow-up. Scand J Gastroenterol. 2018, 53:843-8. 10.1080\/00365521.2018.1477987","journal-title":"Scand J Gastroenterol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.5009\/gnl16488","article-title":"Risk factors for gastric tumorigenesis in underlying gastric mucosal atrophy","volume":"11","author":"Song JH","year":"2017","unstructured":"Song JH, Kim SG, Jin EH, Lim JH, Yang SY. Risk factors for gastric tumorigenesis in underlying gastric mucosal atrophy. Gut Liver. 2017, 11:612-9. 10.5009\/gnl16488","journal-title":"Gut Liver"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s00464-016-5211-4","article-title":"Endoscopic gastric atrophy is strongly associated with gastric cancer development after Helicobacter pylori eradication","volume":"31","author":"Toyoshima O","year":"2017","unstructured":"Toyoshima O, Yamaji Y, Yoshida S, Matsumoto S, Yamashita H, Kanazawa T, Hata K. Endoscopic gastric atrophy is strongly associated with gastric cancer development after Helicobacter pylori eradication. Surg Endosc. 2017, 31:2140-8. 10.1007\/s00464-016-5211-4","journal-title":"Surg Endosc"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-015-1081-0","article-title":"Gastric atrophy and xanthelasma are markers for predicting the development of early gastric cancer","volume":"51","author":"Sekikawa A","year":"2016","unstructured":"Sekikawa A, Fukui H, Sada R, et al.. Gastric atrophy and xanthelasma are markers for predicting the development of early gastric cancer. J Gastroenterol. 2016, 51:35-42. 10.1007\/s00535-015-1081-0","journal-title":"J Gastroenterol"},{"key":"ref16","article-title":"Gastric cancer mortality in a high incidence area: long-term follow-up of Helicobacter pylori-related precancerous lesions in the general population","volume":"16","author":"Boreiri M","year":"2013","unstructured":"Boreiri M, Samadi F, Etemadi A, et al.. Gastric cancer mortality in a high incidence area: long-term follow-up of Helicobacter pylori-related precancerous lesions in the general population. Arch Iran Med. 2013, 16:343-7.","journal-title":"Arch Iran Med"},{"key":"ref17","article-title":"Chronic atrophic gastritis is a progressive disease: analysis of medical reports from Shanghai (1985-2009)","volume":"53","author":"Chooi EY","year":"2012","unstructured":"Chooi EY, Chen HM, Miao Q, et al.. Chronic atrophic gastritis is a progressive disease: analysis of medical reports from Shanghai (1985-2009). Singapore Med J. 2012, 53:318-24.","journal-title":"Singapore Med J"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/apt.15540","article-title":"Natural history of autoimmune atrophic gastritis: a prospective, single centre, long-term experience","volume":"50","author":"Miceli E","year":"2019","unstructured":"Miceli E, Vanoli A, Lenti MV, et al.. Natural history of autoimmune atrophic gastritis: a prospective, single centre, long-term experience. Aliment Pharmacol Ther. 2019, 50:1172-80. 10.1111\/apt.15540","journal-title":"Aliment Pharmacol Ther"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.14309\/ctg.0000000000000237","article-title":"Long-term follow-up of gastric precancerous lesions in a low GC incidence area","volume":"11","author":"Chapelle N","year":"2020","unstructured":"Chapelle N, P\u00e9ron M, Qu\u00e9n\u00e9herv\u00e9 L, et al.. Long-term follow-up of gastric precancerous lesions in a low GC incidence area. Clin Transl Gastroenterol. 2020, 11:e00237. 10.14309\/ctg.0000000000000237","journal-title":"Clin Transl Gastroenterol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2010.04277.x","article-title":"Gastritis OLGA-staging and gastric cancer risk: a twelve-year clinico-pathological follow-up study","volume":"31","author":"Rugge M","year":"2010","unstructured":"Rugge M, de Boni M, Pennelli G, et al.. Gastritis OLGA-staging and gastric cancer risk: a twelve-year clinico-pathological follow-up study. Aliment Pharmacol Ther. 2010, 31:1104-11. 10.1111\/j.1365-2036.2010.04277.x","journal-title":"Aliment Pharmacol Ther"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2020.10.038","article-title":"Endoscopic surveillance at 3 years after diagnosis, according to European guidelines, seems safe in patients with atrophic gastritis in a low-risk region","volume":"53","author":"Esposito G","year":"2021","unstructured":"Esposito G, Dilaghi E, Cazzato M, et al.. Endoscopic surveillance at 3 years after diagnosis, according to European guidelines, seems safe in patients with atrophic gastritis in a low-risk region. Dig Liver Dis. 2021, 53:467-73. 10.1016\/j.dld.2020.10.038","journal-title":"Dig Liver Dis"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2017-314498","article-title":"Surveillance of premalignant gastric lesions: a multicentre prospective cohort study from low incidence regions","volume":"68","author":"den Hollander WJ","year":"2019","unstructured":"den Hollander WJ, Holster IL, den Hoed CM, et al.. Surveillance of premalignant gastric lesions: a multicentre prospective cohort study from low incidence regions. Gut. 2019, 68:585-93. 10.1136\/gutjnl-2017-314498","journal-title":"Gut"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1080\/00365521.2019.1566492","article-title":"Long-term gastric cancer risk in male smokers with atrophic corpus gastritis","volume":"54","author":"Nieminen AA","year":"2019","unstructured":"Nieminen AA, Kontto J, Puolakkainen P, Virtamo J, Kokkola A. Long-term gastric cancer risk in male smokers with atrophic corpus gastritis. Scand J Gastroenterol. 2019, 54:145-51. 10.1080\/00365521.2019.1566492","journal-title":"Scand J Gastroenterol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1177\/2050640618792817","article-title":"UEG Week 2018 Oral Presentations","volume":"6","year":"2018","unstructured":"UEG Week 2018 Oral Presentations. United European Gastroenterol J. 2018, 6.A1-A134. 10.1177\/2050640618792817","journal-title":"United European Gastroenterol J"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/S1590-8658(17)30602-3","article-title":"Preliminary results of 3 years follow-up according to maps guidelines in atrophic gastritis patients","volume":"49","author":"Esposito G","year":"2017","unstructured":"Esposito G, Lahner E, Scalese G, et al.. Preliminary results of 3 years follow-up according to maps guidelines in atrophic gastritis patients. Dig Liver Dis. 2017, 49:218. 10.1016\/S1590-8658(17)30602-3","journal-title":"Dig Liver Dis"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h3867","article-title":"Incidence of gastric cancer among patients with gastric precancerous lesions: observational cohort study in a low risk Western population","volume":"351","author":"Song H","year":"2015","unstructured":"Song H, Ekheden IG, Zheng Z, Ericsson J, Nyr\u00e9n O, Ye W. Incidence of gastric cancer among patients with gastric precancerous lesions: observational cohort study in a low risk Western population. BMJ. 2015, 351:h3867. 10.1136\/bmj.h3867","journal-title":"BMJ"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3109\/00365521.2015.1010570","article-title":"Occurrence of gastric cancer and carcinoids in atrophic gastritis during prospective long-term follow up","volume":"50","author":"Lahner E","year":"2015","unstructured":"Lahner E, Esposito G, Pilozzi E, Purchiaroni F, Corleto VD, Di Giulio E, Annibale B. Occurrence of gastric cancer and carcinoids in atrophic gastritis during prospective long-term follow up. Scand J Gastroenterol. 2015, 50:856-65. 10.3109\/00365521.2015.1010570","journal-title":"Scand J Gastroenterol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/S1590-8658(13)60430-2","article-title":"Endoscopic surveillance in autoimmune gastritis: a follow-up study","volume":"153","author":"Segato S","year":"2013","unstructured":"Segato S, Parravicini M, Montanari M, et al.. Endoscopic surveillance in autoimmune gastritis: a follow-up study. Dig Liver Dis. 2013, 153:4. 10.1016\/S1590-8658(13)60430-2","journal-title":"Dig Liver Dis"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2008.02.030","article-title":"OLGA staging for gastritis: a tutorial","volume":"40","author":"Rugge M","year":"2008","unstructured":"Rugge M, Correa P, Di Mario F, et al.. OLGA staging for gastritis: a tutorial. Dig Liver Dis. 2008, 40:650-8. 10.1016\/j.dld.2008.02.030","journal-title":"Dig Liver Dis"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.5946\/ce.2019.072","article-title":"Assessment of endoscopic gastric atrophy according to the Kimura-Takemoto classification and its potential application in daily practice","volume":"52","author":"Quach DT","year":"2019","unstructured":"Quach DT, Hiyama T. Assessment of endoscopic gastric atrophy according to the Kimura-Takemoto classification and its potential application in daily practice. Clin Endosc. 2019, 52:321-7. 10.5946\/ce.2019.072","journal-title":"Clin Endosc"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.21037\/tcr.2020.01.54","article-title":"Risk for gastric cancer in patients with gastric atrophy: a systematic review and meta-analysis","volume":"9","author":"Sui Z","year":"2020","unstructured":"Sui Z, Chen J, Li P, Shao L, Ye J, Lu X, Cai J. Risk for gastric cancer in patients with gastric atrophy: a systematic review and meta-analysis. Transl Cancer Res. 2020, 9:1618-24. 10.21037\/tcr.2020.01.54","journal-title":"Transl Cancer Res"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2024.02.008","article-title":"Gastric cancer screening in Western countries: a call to action","volume":"56","author":"Farinati F","year":"2024","unstructured":"Farinati F, Pelizzaro F. Gastric cancer screening in Western countries: a call to action. Dig Liver Dis. 2024, 56:1653-62. 10.1016\/j.dld.2024.02.008","journal-title":"Dig Liver Dis"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1103042","article-title":"Incidence of adenocarcinoma among patients with Barrett's esophagus","volume":"365","author":"Hvid-Jensen F","year":"2011","unstructured":"Hvid-Jensen F, Pedersen L, Drewes AM, S\u00f8rensen HT, Funch-Jensen P. Incidence of adenocarcinoma among patients with Barrett's esophagus. N Engl J Med. 2011, 365:1375-83. 10.1056\/NEJMoa1103042","journal-title":"N Engl J Med"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1055\/a-0859-1883","article-title":"Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019","volume":"51","author":"Pimentel-Nunes P","year":"2019","unstructured":"Pimentel-Nunes P, Lib\u00e2nio D, Marcos-Pinto R, et al.. Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019. Endoscopy. 2019, 51:365-88. 10.1055\/a-0859-1883","journal-title":"Endoscopy"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2018-318126","article-title":"British Society of Gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma","volume":"68","author":"Banks M","year":"2019","unstructured":"Banks M, Graham D, Jansen M, et al.. British Society of Gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma. Gut. 2019, 68:1545-75. 10.1136\/gutjnl-2018-318126","journal-title":"Gut"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2021.06.078","article-title":"AGA clinical practice update on the diagnosis and management of atrophic gastritis: expert review","volume":"161","author":"Shah SC","year":"2021","unstructured":"Shah SC, Piazuelo MB, Kuipers EJ, Li D. AGA clinical practice update on the diagnosis and management of atrophic gastritis: expert review. Gastroenterology. 2021, 161:1325-1332.e7. 10.1053\/j.gastro.2021.06.078","journal-title":"Gastroenterology"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/306355-incidence-of-gastric-adenocarcinoma-in-those-with-gastric-atrophy-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T08:47:51Z","timestamp":1729241271000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/306355-incidence-of-gastric-adenocarcinoma-in-those-with-gastric-atrophy-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,18]]},"references-count":36,"URL":"https:\/\/doi.org\/10.7759\/cureus.71768","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,18]]}}}